Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA: 600566)

Hubei Jumpcan Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 5, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	25,384	28,972	25,092	25,173	17,969	19,705
Market Cap Growth	9.12%	15.46%	-0.32%	40.09%	-8.81%	-27.88%
Enterprise Value	15,117	19,711	18,865	20,556	14,633	18,236
Last Close Price	27.54	30.31	25.46	25.74	17.94	20.28
PE Ratio	8.97	9.84	10.65	13.48	11.73	10.19
PS Ratio	2.79	3.00	2.79	3.30	2.91	2.84
PB Ratio	1.88	2.17	2.21	2.76	2.31	3.23
P/FCF Ratio	9.95	9.16	10.56	15.29	13.29	12.31
P/OCF Ratio	10.32	8.36	9.57	13.29	10.09	9.17
EV/Sales Ratio	1.67	2.04	2.10	2.69	2.37	2.63
EV/EBITDA Ratio	4.98	6.20	7.37	10.47	8.78	8.96
EV/EBIT Ratio	5.52	6.84	8.37	12.30	10.56	10.12
EV/FCF Ratio	5.92	6.23	7.94	12.49	10.82	11.39
Debt / Equity Ratio	0.10	0.08	0.04	0.07	0.08	0.09
Debt / EBITDA Ratio	0.45	0.34	0.16	0.32	0.36	0.28
Debt / FCF Ratio	0.53	0.34	0.17	0.38	0.45	0.36
Asset Turnover	0.53	0.58	0.66	0.67	0.64	0.84
Inventory Turnover	2.86	4.05	4.01	3.90	3.66	3.38
Quick Ratio	3.12	2.99	3.13	2.75	3.18	2.47
Current Ratio	3.29	3.10	3.26	2.90	3.34	2.67
Return on Equity (ROE)	22.23%	22.87%	21.20%	20.33%	18.42%	28.07%
Return on Assets (ROA)	9.94%	10.88%	10.39%	9.22%	9.03%	13.69%
Return on Capital (ROIC)	12.52%	13.75%	13.10%	11.52%	11.51%	17.75%
Earnings Yield	11.15%	9.74%	8.65%	6.83%	7.11%	8.24%
FCF Yield	10.05%	10.91%	9.47%	6.54%	7.52%	8.13%
Dividend Yield	4.72%	4.29%	3.46%	2.64%	2.51%	6.07%
Payout Ratio	60.44%	29.16%	27.89%	23.81%	78.98%	61.94%
Buyback Yield / Dilution	-0.24%	-0.91%	-0.91%	-7.82%	-2.36%	-0.02%
Total Shareholder Return	4.49%	3.38%	2.55%	-5.18%	0.15%	6.05%

Source: S&P Capital IQ. Standard template. Financial Sources.